Taken together, our findings, for the first time, demonstrated that PHLPP2 acts as a tumor suppressor gene in CRC by restraining the Nrf2-ARE signaling pathway and increasing ROS levels, thus affecting the stemness of CRC cells. The gene discussed is PHLPP2; the disease is neoplasm.